ArticleThe World Allergy Organization journal2026
Comparison of the efficacy of different doses of omalizumab (150 mg vs 300 mg) in patients with seasonal allergic rhinitis and low total IgE: A randomized, double-blind, controlled study.
Lisha Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.